DK130475A - - Google Patents
Info
- Publication number
- DK130475A DK130475A DK130475A DK130475A DK130475A DK 130475 A DK130475 A DK 130475A DK 130475 A DK130475 A DK 130475A DK 130475 A DK130475 A DK 130475A DK 130475 A DK130475 A DK 130475A
- Authority
- DK
- Denmark
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45679774A | 1974-04-01 | 1974-04-01 | |
| US54722775A | 1975-02-05 | 1975-02-05 | |
| US55496675A | 1975-03-03 | 1975-03-03 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK130475A true DK130475A (OSRAM) | 1975-10-02 |
| DK138743B DK138743B (da) | 1978-10-23 |
| DK138743C DK138743C (OSRAM) | 1979-04-02 |
Family
ID=27412681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK130475AA DK138743B (da) | 1974-04-01 | 1975-03-26 | Analogifremgangsmåde til fremstilling af 1-oxo-1H-pyrimido (1,2-a)quinolin-2-carboxylsyre-forbindelser. |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5427360B2 (OSRAM) |
| CA (1) | CA1033731A (OSRAM) |
| DD (1) | DD119425A5 (OSRAM) |
| DE (1) | DE2513930A1 (OSRAM) |
| DK (1) | DK138743B (OSRAM) |
| ES (1) | ES436155A1 (OSRAM) |
| FI (1) | FI750891A7 (OSRAM) |
| FR (1) | FR2265389B1 (OSRAM) |
| GB (1) | GB1451423A (OSRAM) |
| IE (1) | IE40893B1 (OSRAM) |
| IL (1) | IL46864A0 (OSRAM) |
| LU (1) | LU72184A1 (OSRAM) |
| NL (1) | NL7503692A (OSRAM) |
| PH (1) | PH10464A (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4075343A (en) * | 1976-09-13 | 1978-02-21 | Pfizer Inc. | Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof |
| US4127720A (en) * | 1977-09-21 | 1978-11-28 | Bristol-Myers Company | Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity |
| US4209620A (en) * | 1978-06-19 | 1980-06-24 | Bristol-Myers Company | Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity |
| US4472401A (en) * | 1981-11-27 | 1984-09-18 | Roussel Uclaf | Pyrimido-quinoxalines having antiallergic properties |
| US4510143A (en) * | 1982-02-17 | 1985-04-09 | Roussel Uclaf | Antiallergic pyrimido[1,2-a]quinoxalin-2-carboxylic acid derivatives |
| AU5533996A (en) * | 1996-04-04 | 1997-10-29 | University Of Nebraska Board Of Regents | Synthetic triple helix-forming compounds |
| US6989392B2 (en) | 2002-06-18 | 2006-01-24 | Abbott Laboratories | 2-Aminoquinolines as melanin concentrating hormone receptor antagonists |
-
1975
- 1975-03-17 CA CA222,180A patent/CA1033731A/en not_active Expired
- 1975-03-18 IL IL46864A patent/IL46864A0/xx unknown
- 1975-03-24 PH PH16958A patent/PH10464A/en unknown
- 1975-03-25 FI FI750891A patent/FI750891A7/fi not_active Application Discontinuation
- 1975-03-26 DE DE19752513930 patent/DE2513930A1/de not_active Ceased
- 1975-03-26 DK DK130475AA patent/DK138743B/da not_active IP Right Cessation
- 1975-03-27 GB GB1305575A patent/GB1451423A/en not_active Expired
- 1975-03-27 NL NL7503692A patent/NL7503692A/xx not_active Application Discontinuation
- 1975-03-31 ES ES436155A patent/ES436155A1/es not_active Expired
- 1975-04-01 LU LU72184A patent/LU72184A1/xx unknown
- 1975-04-01 DD DD185117A patent/DD119425A5/xx unknown
- 1975-04-01 JP JP4022375A patent/JPS5427360B2/ja not_active Expired
- 1975-04-01 FR FR7510140A patent/FR2265389B1/fr not_active Expired
- 1975-04-02 IE IE711/75A patent/IE40893B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5427360B2 (OSRAM) | 1979-09-10 |
| DK138743C (OSRAM) | 1979-04-02 |
| IL46864A0 (en) | 1975-05-22 |
| DD119425A5 (OSRAM) | 1976-04-20 |
| NL7503692A (nl) | 1975-10-03 |
| DE2513930A1 (de) | 1975-10-02 |
| JPS50140499A (OSRAM) | 1975-11-11 |
| DK138743B (da) | 1978-10-23 |
| CA1033731A (en) | 1978-06-27 |
| FR2265389B1 (OSRAM) | 1978-07-28 |
| LU72184A1 (OSRAM) | 1976-03-02 |
| GB1451423A (en) | 1976-10-06 |
| IE40893L (en) | 1975-10-01 |
| ES436155A1 (es) | 1977-02-01 |
| IE40893B1 (en) | 1979-09-12 |
| AU7937775A (en) | 1976-09-23 |
| PH10464A (en) | 1977-04-25 |
| FI750891A7 (OSRAM) | 1975-10-02 |
| FR2265389A1 (OSRAM) | 1975-10-24 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed | ||
| PUP | Patent expired |